Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients

Updated: Sep 28, 2018

Irene Ghobrial, MD of Dana-Farber Cancer Institute, Boston, MA, discusses the benefits of early therapeutic interventions for patients with high-risk smouldering multiple myeloma (MM). +watch video

Recent Posts

See All

Honoring a decade of Standing Up To Cancer

On September 7, Stand Up To Cancer’s (SU2C) telecast shared inspiring stories of hope, perseverance, and groundbreaking cancer research to a worldwide audience. +read more

DFCI Logo Lens Stacked PNG_edited.png

© 2018 Dana-Farber Cancer Institute |  Terms of Use  |   Privacy Policy